Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × Quercetin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Frailty 1 Fanconi Anemia 1 Carcinoma, Squamous Cell 1

Interventions

peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 cabozantinib 1 Temozolomide 1 Quercetin 1 Protons 1 Photons 1 Flavonoids 1 Dasatinib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04733534 2026-01-20

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Frailty, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡